GlassScriptPhysician profile
Michael David Marling
NPI 1639494586
$9,065.11
in general payments reported to CMS, 2019-2025
33 companies · $629 in 2025
The $629 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,019 · 2020: $90.16 · 2021: $367 · 2022: $626 · 2023: $754 · 2024: $579 · 2025: $629.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,962.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,961.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $5,823.29 | 2019 | |
| Smith+Nephew, INC. | $541.16 | 2019-2025 | Collagenase Santyl |
| Organogenesis INC. | $373.00 | 2021-2025 | Puraply, Cygnus Dual, Puraply Wound Matrix |
| Paratek Pharmaceuticals, INC. | $337.29 | 2023-2025 | Nuzyra |
| Kowa Pharmaceuticals America, INC. | $298.99 | 2022-2023 | Seglentis |
| Acera Surgical, INC. | $252.20 | 2020-2025 | Restrata Wound Matrix |
| Horizon Therapeutics Plc | $195.22 | 2019-2023 | Krystexxa |
| Globus Medical, INC. | $187.82 | 2025 | Senza |
| Kerecis Limited | $173.70 | 2022-2025 | Kerecis Omega3 Surgiclose, Kerecis Surgiclose, Kerecis Omega3 Graftguide |
| Stryker Corporation | $133.08 | 2024-2025 | Ortholoc 3di, Dart-Fire, Prostep Mica |
| Mimedx Group, INC. | $88.82 | 2024-2025 | |
| Depuy Synthes Sales INC. | $65.86 | 2024 | Motoband, Speedbutton, Minibunion |
| Integra Lifesciences Corporation | $64.86 | 2019-2021 | |
| Abbott Laboratories | $58.32 | 2023-2025 | Eterna |
| Polynovo North America LLC | $47.08 | 2024 | Novosorb Btm |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $43.54 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $37.90 | 2019 | |
| Baudax Bio INC. | $34.96 | 2020-2021 | |
| Biocomposites INC | $33.78 | 2023-2025 | Stimulan |
| Treace Medical Concepts, INC. | $29.14 | 2024-2025 | |
| Biotissue Holdings INC. | $28.81 | 2023 | |
| Boston Scientific Corporation | $27.40 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Next Science LLC | $25.34 | 2024 | Surgx, Xperience, Blastx |
| Solventum Corporation | $22.45 | 2024 | Activ.A.C. |
| Nevro Corp. | $21.52 | 2024 | Senza |
| Alfasigma USA, INC. | $18.09 | 2020 | |
| Zimmer Biomet Holdings, INC. | $16.00 | 2019 | |
| Aroa Biosurgery Incorporated | $15.82 | 2019-2020 | |
| Titan Surgical Group, LLC | $15.69 | 2025 | |
| Amgen INC. | $15.36 | 2025 | Krystexxa |
| Abbvie INC. | $14.78 | 2022 | |
| Medtronic, INC. | $13.50 | 2023 | Intellis Adaptivestim |
| Arteriocyte Medical Systems, INC. | $10.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Marling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.